Market closed

Sartorius/€SRT3

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Sartorius

Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.

Ticker

€SRT3

Trading on

XETRA

Industry

Life Sciences Tools & Services

Employees

13,762

Sartorius Metrics

BasicAdvanced
€14B
Market cap
-
P/E ratio
-
EPS
0.93
Beta
€0.74
Dividend rate
0.34%
Dividend yield
€14B
0.93
€261.80
€201.50
90K
€0.74
2.015
0.995
117.182
119.798
65.67%
1.85%
2.80%
3.88%
0.34%
0.34%
-7.87%
1.46%
1.87%

What the Analysts think about Sartorius

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Sartorius stock.

Sartorius Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Sartorius Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy €SRT3

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sartorius stock?

Sartorius (SRT3) has a market cap of €14B as of December 22, 2024.

What is the P/E ratio for Sartorius stock?

The price to earnings (P/E) ratio for Sartorius (SRT3) stock is 0 as of December 22, 2024.

Does Sartorius stock pay dividends?

Yes, the Sartorius (SRT3) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is €0.74 and the yield is 0.34%. Sartorius has a payout ratio of 65.67% on a trailing twelve-month basis.

When is the next Sartorius dividend payment date?

The next Sartorius (SRT3) dividend payment date is unconfirmed.

What is the beta indicator for Sartorius?

Sartorius (SRT3) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.